Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

AM Rx vs FuturHealth

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

5.9

AM Rx

Best for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully)
★★★☆☆3

Starting at $25/mo

Compounded SemaglutideOzempicWegovyZepbound
Visit AM Rx
6.7

FuturHealth

Best for readers who want both brand-name and compounded GLP-1 options on one platform with registered-dietitian nutrition coaching, AND are willing to read the data-breach litigation disclosure before signing up
★★★☆☆3.4

Starting at $199/mo

Brand WegovyBrand ZepboundBrand OzempicBrand Mounjaro
Visit FuturHealth

Side-by-Side Comparison

FeatureAM RxFuturHealth
Overall Score5.9/106.7/10
Starting Price$25/mo$199/mo
Editorial Rating3 ★ /53.4 ★ /5
Features6 features8 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA Warnings2 warningsNone

Pros & Cons

AM Rx

Pros

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available (not just async) with providers averaging 10+ years experience
  • Compounded semaglutide from $151/mo quarterly

Cons

  • Active FTC/DOJ lawsuit for deceptive billing and subscription practices (ROSCA violations)
  • Two FDA warning letters (Sept 2025, Feb 2026) for misbranding compounded GLP-1 products
  • Novo Nordisk false advertising lawsuit (Aug 2025)
  • Parent entity Zealthy has BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5 — 85% one-star reviews citing billing disputes and unreachable support
  • No visible LegitScript certification or PCAB accreditation
  • No named pharmacy partners — compounding source not disclosed
  • No FDA compounding disclaimer on the website
  • State availability not publicly disclosed
  • Founder Kyle Robertson previously ran Cerebral, which settled FTC charges for similar practices
  • Same corporate entity (FitRX LLC) as Zealthy and FitRx — shares regulatory history

FuturHealth

Pros

  • LegitScript Certified and HITRUST Certified — two independently verifiable telehealth/health-data trust marks
  • Both brand-name (Ozempic, Wegovy, Mounjaro, Zepbound) and clinician-discretionary compounded options on one platform
  • Bundled registered-dietitian nutrition guidance — most pure-Rx telehealths leave nutrition support to the patient

Cons

  • ACTIVE LITIGATION: Wilson v. FuturHealth Inc., U.S. District Court Southern District of California, Case No. 3:2025cv00157, alleging unauthorized access to G-Plans subscriber data on/before October 16, 2024 and asserting CCPA, medical-confidentiality, and negligence claims. Material disclosure for any reader signing up.
  • BBB complaint pattern: multiple consumer reports of recurring unauthorized charges (e.g. $396/month) without medication being received — verify cancellation flow before subscribing
  • Pharmacy partners are described as 'licensed, U.S.-based pharmacies' but no specific 503A/503B partners are publicly named
  • Pricing is not displayed on the public landing page — visible only after qualification questionnaire/portal login
  • Clinical platform is white-labeled on top of SteadyMD and OpenLoop infrastructure — FuturHealth is the front-end brand, not the first-party prescribing entity

Our Verdict

Winner: FuturHealthScore: 6.7/10

FuturHealth edges out AM Rx with a higher overall score of 6.7/10 and is particularly strong for readers who want both brand-name and compounded GLP-1 options on one platform with registered-dietitian nutrition coaching, AND are willing to read the data-breach litigation disclosure before signing up. AM Rx remains a solid alternative, especially if you're looking for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.